Contains fulltext : 71202.pdf (publisher's version ) (Closed access)Minor histocompatibility antigens (mHAgs) constitute the target antigens of the T cell-mediated graft-versus-leukemia response after HLA-identical allogeneic stem cell transplantation (SCT). Several human mHAgs have been identified, but only a few are selectively expressed by hematopoietic cells representing potential targets for specific immunotherapy. Molecular approaches including cDNA library screening and genetic linkage analysis have been successfully applied to identify T cell-defined mHAgs, but each approach has its drawbacks which may lead to mis-identification of the mHAg of interest. We improved both molecular strategies to facilitate more robus...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
BACKGROUND: Minor Histocompatibility (H) antigen mismatches significantly influence the outcome of H...
Contains fulltext : 70575.pdf (publisher's version ) (Open Access)Some minor histo...
Contains fulltext : 30117_charoflea.pdf (publisher's version ) (Open Access)This t...
Allogeneic stem cell transplantation (alloSCT) can be a curative treatment for h...
Purpose: Identification of minor histocompatibility antigens (mHag) with classic methods often requi...
T cells recognizing the highly immunogenic minor histocompatibility antigens (mHags) expressed by he...
Some minor histocompatibility antigens (mHags) are expressed exclusively on patient hematopoietic an...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
BACKGROUND: After allogeneic hematopoietic stem-cell transplantation (HSCT), donor-derived T cells m...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
BACKGROUND: Minor Histocompatibility (H) antigen mismatches significantly influence the outcome of H...
Contains fulltext : 70575.pdf (publisher's version ) (Open Access)Some minor histo...
Contains fulltext : 30117_charoflea.pdf (publisher's version ) (Open Access)This t...
Allogeneic stem cell transplantation (alloSCT) can be a curative treatment for h...
Purpose: Identification of minor histocompatibility antigens (mHag) with classic methods often requi...
T cells recognizing the highly immunogenic minor histocompatibility antigens (mHags) expressed by he...
Some minor histocompatibility antigens (mHags) are expressed exclusively on patient hematopoietic an...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
BACKGROUND: After allogeneic hematopoietic stem-cell transplantation (HSCT), donor-derived T cells m...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is routinely used to treat hematopoie...
BACKGROUND: Minor Histocompatibility (H) antigen mismatches significantly influence the outcome of H...